The pharmaceutical industry is witnessing significant advancements in drug development due to the integration of artificial intelligence (AI), particularly with the launch of AlphaFold 3 on May 8. This new AI model, developed by Google DeepMind, is described as a 'leap forward' in understanding biological processes. It is expected to dramatically accelerate biological research by offering a potent new tool for predicting protein functions. The European Medicines Agency (EMA) noted a 'huge interest' in AI for drug development. Additionally, a study by Boston Consulting Group highlights that drugs discovered using AI have a higher success rate in early-stage trials, approximately 80-90%, compared to the historic average of 40-65%. AlphaFold 3 also introduces features like the Alphafold Server, which facilitates research on protein-ligand interactions, and directly addresses safety concerns, a notable improvement from previous versions.
Major AlphaFold upgrade offers boost for drug discovery https://t.co/bnj5wCEJdu
“A study by Boston Consulting Group published this week suggests that drugs discovered by AI have a higher success rate in early stage trials than those discovered by other methods.” https://t.co/KJN8F5oQ6u
Google DeepMind's 'Leap Forward' in AI Could Unlock Secrets of Biology https://t.co/H4XVuozql9
A first analysis of clinical trial data (primarily phase 1) from #AI-supported molecules suggests a higher success rate (~80-90%) than historic averages (~40-65%) 🤖 📊 AI techniques are making inroads into #drug discovery 💊💉 by @BCG https://t.co/1tWk8mouyS https://t.co/FzAux7Dxl1
Getting Ready for Generative AI in Academic Medical Centers https://t.co/APRJHmT9J6
The innovative AI model, announced on May 8, is likely to dramatically accelerate biological research https://t.co/KdVblwCDvK
An #AI-powered software program offers scientists a potent new tool to predict how proteins work. https://t.co/WoCPnWUKcY
Absolutely incredible new development. Key noteworthy items: 1. Also launching Alphafold Server - lowering the threshold for starting working on protein protein / ligand interactions (not sure about privacy) 2. Acknowledges the safety issue head on. Not so in previous… https://t.co/PyRuXoUvzK
AlphaFold 3 is here! I was super lucky to have had access to it for a bit now, and it is absolutely amazing. This might be the very first video out there that you see on it - enjoy! https://t.co/wsiDGz3Pio #alphafold
AlphaFold 3 is here! A follow up to one of the best papers ever written (in my opinion). I was super lucky to have had access to it for a bit now, and I’ll tell you all the incredible things I’ve found in the video below. Perhaps this is the first video out there talking about…
Google DeepMind’s ‘leap forward’ in AI could unlock secrets of biology https://t.co/VzFCc6MDMq
Pharma Industry Has Shown ‘Huge Interest’ In AI For Drug Development, Says EMA https://t.co/oYTlRxWJ7S #PinkSheet
Generative AI Finds Its Footing in Drug Development | BioSpace https://t.co/PjHxx2spTg